Back to search

University of Southampton

Development of second generation cyclic peptide inhibitors of hypoxia inducible factors

Abstract

dc:description.abstract

Hypoxia-inducible factors (HIFs) are heterodimeric transcription factors that function as the master regulators of the cellular response to low oxygen concentrations. HIFs upregulate the expression of genes that promote growth and initiate metabolic changes, which subsequently aid survival and reoxygenation under these conditions. Tumour cores often contain oxygen-depleted regions that exhibit high levels of HIF activity, subsequently triggering this biochemical response. HIF activity is thought to be associated with the aggressive growth, metastasis and greater persistence phenotypes exhibited by such tumours. As such the inhibition of the HIF pathway is considered to be an attractive target in the development of new cancer therapeutics.<br/><br/>This work presents a set of novel cyclic peptide inhibitors of the HIF pathway, which function by disrupting a key protein-protein interaction between the α and β subunits of the HIF heterodimeric transcription factor. These peptides were selected for their ability to inhibit both isoforms of the HIF-α subunit. The affinity of the peptides for each of these was determined and from this, a lead peptide was identified.<br/><br/>The structure-activity relationship of the lead peptide with the protein target has been explored, through use of alanine scanning and incorporation of unnatural amino acid derivatives. This approach has led to the identification of an optimised HIF inhibitor that exhibits a binding affinity below the μM threshold.<br/><br/>A series of in vitro assays to detect HIF dimerization have also been designed and utilised. The effects of the inhibitory peptides on these systems has also been investigated.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ball, Andrew Tomas
Advisor dc:contributor.advisor
  • Tavassoli, Ali
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ball, Andrew Tomas. Development of second generation cyclic peptide inhibitors of hypoxia inducible factors. doctoral thesis, University of Southampton, 2018.